Concepedia

Xuanfei Li

XL

Statistics

Publications

11

Citations

267

H-Index

11

Active since

2014

Affiliations

Zhongnan Hospital of Wuhan University(Current)

Wuhan University

Second Affiliated Hospital of Chongqing Medical University

Dalian Medical University

Chongqing Medical University

Xuanfei Li is an author at Zhongnan Hospital of Wuhan University specializing in pharmacology, oncology, and molecular oncology.

ORCID

Publications per year

2014–2024

11

Publications

11

Pre-conditioning with tanshinone IIA attenuates the ischemia/reperfusion injury caused by liver grafts via regulation of HMGB1 in rat Kupffer cells

Xuanfei Li, Yakun Wu, Wenfeng Zhang et al. · Biomedicine & Pharmacotherapy · 2017 · 43 citations

, , +16

Nobiletin attenuates lipopolysaccharide/D-galactosamine-induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF-κB-mediated cytokine production

Zhenxing He, Xuanfei Li, Hao Chen et al. · Molecular Medicine Reports · 2016 · 38 citations · Full text

, , +17

Ultrasound-targeted microbubble destruction-mediated downregulation of CD133 inhibits epithelial-mesenchymal transition, stemness and migratory ability of liver cancer stem cells

Yanmin Liu, Xuanfei Li, Hao Liu et al. · Oncology Reports · 2015 · 33 citations · Full text

, , +17

Agmatine Protects against Zymosan-Induced Acute Lung Injury in Mice by Inhibiting NF-<i>κ</i>B-Mediated Inflammatory Response

Xuanfei Li, Zheng Liu, Jin He et al. · BioMed Research International · 2014 · 27 citations · Full text

, , +17

DNMBP-AS1 Regulates NHLRC3 Expression by Sponging miR-93-5p/17-5p to Inhibit Colon Cancer Progression

Lijie Yang, Tiecheng Yang, Huaqiao Wang et al. · Frontiers in Oncology · 2022 · 26 citations · Full text

, , +17

1–5 of 11